Mortality after surgery in patients with liver cirrhosis: Comparison of Child-Turcotte-Pugh, MELD and MELDNa score

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 1, 2011, Pages 51-59

  Cho, Hyun Chin ^a   Jung, Han Young ^a   Sinn, Dong Hyun ^a   Choi, Moon Seok ^a   Koh, Kwang Cheol ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a   Kim, Seon Woo ^a   Lee, Joon Hyeok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Child Turcotte Pugh; liver cirrhosis; Model for End stage Liver Disease and Serum Sodium Concentration; Model for End stage Liver Disease score; postoperative mortality

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CHILD TURCOTTE PUGH SCORE; COMPARATIVE STUDY; EMERGENCY SURGERY; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODEL FOR END STAGE LIVER DISEASE AND SERUM SODIUM CONCENTRATION SCORE; MODEL FOR END STAGE LIVER DISEASE SCORE; NONPARAMETRIC TEST; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER FAILURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 78650782185     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283407158     Document Type: Article

References (26)

1. Rice HE, O'Keefe GE, Helton WS, Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997; 132:880-884. discussion 884-885.
2. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999; 29:1617-1623.
3. Patel T. Surgery in the patient with liver disease. Mayo Clin Proc 1999; 74:593-599.
4. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1:1-85.
5. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199:648-655.
6. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: Still a major surgical challenge. Surgery 1997; 122:730-735. discussion 735-736.
7. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
8. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91-96.
9. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188:580-583.
10. Hoteit MA, Ghazale AH, Bain AJ, Rosenberg ES, Easley KA, Anania FA, et al. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis. World J Gastroenterol 2008; 14:1774-1780.
11. Suman A, Barnes DS, Zein NN, Levinthal GN, Connor JT, Carey WD. Predicting outcome after cardiac surgery in patients with cirrhosis: A comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol 2004; 2:719-723.
12. Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2004; 2:1123-1128.
13. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: Model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 2005; 140:650-654. discussion 655.
14. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007; 132:1261-1269.
15. Millwala F, Nguyen GC, Thuluvath PJ. Outcomes of patients with cirrhosis undergoing non-hepatic surgery: Risk assessment and management. World J Gastroenterol 2007; 13:4056-4063.
16. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-343.
17. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40:802-810.
18. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41:32-39.
19. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130:1652-1660.
20. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359:1018-1026.
21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44:837-845.
22. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90:42-53.
23. Aranha GV, Sontag SJ, Greenlee HB. Cholecystectomy in cirrhotic patients: A formidable operation. Am J Surg 1982; 143:55-60.
24. Del Olmo JA, Flor-Lorente B, Flor-Civera B, Rodriguez F, Serra MA, Escudero A, et al. Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg 2003; 27:647-652.
25. Leonetti JP, Aranha GV, Wilkinson WA, Stanley M, Greenlee HB. Umbilical herniorrhaphy in cirrhotic patients. Arch Surg 1984; 119: 442-445.
26. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005; 242:244-251.